|
Ethyl 3-benzyl-1-{2-[(4-fluorophenyl)amino]-2-oxoethyl}-2,4-dioxo-1,3,4,5,6,8-hexahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidine-7(2H)-carboxylate |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
N-(4-cyanophenyl)-2-(4-fluoro-2-methylanilino)acetamide |
Depiction based on curated SMILES
N
N
H
O
CH
3
NH
F
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
N-cyclohexyl-2-(2,3-dioxo-2,3-dihydro-1H-indol-1-yl)acetamide |
Depiction based on curated SMILES
N
O
O
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
von Ambüren J, et al. 2020. Microorganisms |
|
M8 (internal name in literature) |
Depiction based on curated SMILES
N
O
H
3
C
CH
3
N
CH
3
N
S
O
HN
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
M41 (internal name in literature) |
Depiction based on curated SMILES
N
N
CH
3
N
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[(5Z)-5-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-4-oxo-2-phenylimino-1,3-thiazolidin-3-yl]-3-(4-phenylphenyl)propanoyl]amino]pentanamide |
Depiction based on curated SMILES
O
N
H
H
HN
HN
NH
2
NH
2
O
O
O
CH
3
OH
O
S
N
H
3
C
N
H
|
Salmonella |
TTSS (SPI-1 encode) |
Preclinical (in vitro) |
Felise HB, et al. 2008. Cell Host Microbe |
|
N'-[(E)-(3-ethoxy-2-hydroxyphenyl)methylideneamino]oxamide |
Depiction based on curated SMILES
N
OH
O
NH
2
O
NH
H
3
C
O
|
Salmonella |
TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother |
|
N'-[(E)-(5-bromo-2-hydroxyphenyl)methylideneamino]oxamide |
Depiction based on curated SMILES
H
2
N
O
O
NH
N
Br
OH
|
Salmonella Shigella |
TTSS (SPI-1 encode); TTSS (SPI-2 encode) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother Veenendaal AK, et al. 2009. J Bacteriol |
|
CCG-38543 (internal name in literature) |
Depiction based on curated SMILES
N
H
CH
3
OH
H
N
O
H
CH
3
O
OH
N
H
O
H
|
Shigella |
VirF |
Preclinical (in vitro) |
Hurt JK, et al. 2010. J Biomol Screen |
|
[(2R)-6-azaniumyl-1-[3-[3-[[(2R)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-hexadecanoylamino]propylamino]-1-oxohexan-2-yl]azanium |
Depiction based on curated SMILES
+
N
H
H
H
N
H
O
H
H
+
N
H
H
H
+
N
H
H
H
CH
3
O
N
N
H
O
H
+
N
H
H
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Konai MM, et al. 2015. ACS Infect Dis |
|
| | |